IPEX syndrome is a severe autoimmune disease with limited treatment options caused by mutations in the forkhead box protein 3 (FOXP3) gene, which plays a critical role in immune regulation.
Polycythemia vera is a rare blood cancer characterized by the hyperproliferation of red blood cells, leading to coagulation events like strokes and heart attacks.
Ultrasound technology is a safe, high-resolution, and cost-efficient tool for imaging. Other modalities, such as MRI or CT, may require the use of anesthesia. This makes it difficult to image pediatric patients and patients sensitive to anesthesia.
Stanford inventors have engineered a method for breath-based cancer detection, which can provide rapid and non-invasive early cancer detection and surveillance.
Inventors at Stanford University have developed a colorimetric device to visualize microstructural features in tissue biopsies towards clinical diagnostics.
Stanford inventors have developed a method of using CRISPR/Cas9 or similar gene editing technologies to genetically edit an individual's own myeloid cells for specific gene targets, which are critical to wound repair, and applying these edited cells in a hydrogel to promote ra
Researchers in Prof. David Myung's laboratory have developed a bio-compatible, crosslinking gel that can be used for in situ repair of damaged cornea or as a three-dimensional scaffold for keratocyte-keratinocyte tissue culture.
Using their newly developed acetyl-click screening platform, researchers at Stanford have identified riboflavin analogs as small molecule inhibitors of Histone Acetyltransferase 1 (HAT1) with anti-cancer activity.
Stanford researchers have developed a contrastive learning approach that can significantly reduce the amount of labeled electrocardiogram (ECG) data required for downstream healthcare tasks, such as arrhythmia identification.
Stanford researchers in the Mahajan Lab have created a customizable proteomics platform that can identify protein biomarkers to differentiate among ischemic eye diseases and identify novel therapeutic targets to treat them.